CTKB - Cytek Biosciences, Inc.
4.32
-0.260 -6.019%
Share volume: 556,843
Last Updated: 03-27-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$4.58
-0.26
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-06-2024 | 11-06-2024 | 02-27-2025 | 05-08-2025 | 11-05-2025 | 02-26-2026 | |
| Cash flow financing | 1.613 M | -1.711 M | -12.084 M | -3.640 M | -11.545 M | 1.941 M | -1.226 M | |
| Other financing cash flows | 358.000 K | 94.000 K | 1.000 K | 1.712 M | -90.000 K | -34.000 K | -183.000 K | |
| Cash flow | -184.000 K | 6.515 M | -14.672 M | -65.076 M | -2.218 M | 16.963 M | -3.839 M | |
| Net income | -6.169 M | -10.434 M | 941.000 K | 9.642 M | -11.402 M | -5.478 M | -44.076 M | |
| Depreciation | 1.699 M | 1.808 M | 1.851 M | 1.854 M | 1.875 M | 1.918 M | 1.896 M | |
| Changes in inventories | -4.773 M | 0.000 | 0.000 | 0.000 | 1.503 M | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -5.754 M | 2.022 M | -15.809 M | -63.433 M | 9.452 M | 18.920 M | -1.842 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 567.000 K | 1.053 M | 990.000 K | 703.000 K | 816.000 K | 656.000 K | 806.000 K | |
| Cash Change | 1.511 M | 8.777 M | -15.615 M | -63.558 M | -3.446 M | 17.809 M | -2.427 M |